Kasamo, Sachiko
Takeuchi, Masato
Ikuno, Masashi
Kawasaki, Yohei
Tanaka, Shiro
Takahashi, Ryosuke
Kawakami, Koji http://orcid.org/0000-0002-7477-4071
Funding for this research was provided by:
Dainippon Sumitomo Pharma (Collaborative research fund)
Article History
Received: 9 February 2019
Revised: 1 May 2019
Accepted: 3 May 2019
First Online: 10 May 2019
Compliance with ethical standards
:
: Shiro Tanaka has received consultation or outsourcing fee from the Pharmaceuticals and Medical Devices Agency, DeNA Life Science Inc., Boehringer Ingelheim Co. Ltd, Public Health Research Foundation, Japan Breast Cancer Research Group, and Satt Co. Ltd; grants from the Japan Agency for Medical Research and Development, the Japanese Ministry of Health Labour and Welfare, and the Japanese Ministry of Education, Science, and Technology. Ryosuke Takahashi is an employee of the Japan Agency for Medical Research and Development; has served on advisory boards for Kan Institute Co. Ltd, and Sumitomo Dainippon Pharma Co. Ltd; has performed corporate-sponsored research for Novartis Pharma K.K. Co., Otsuka Pharmaceutical Co. Ltd, Pfizer Japan Inc., Takeda Pharmaceuticals Co. Ltd, Nippon Boehringer Ingelheim Co. Ltd, Sumitomo Dainippon Pharma Co. Ltd, Kyowa Hakko-Kirin Co. Ltd, Nihon Medi-physics Co. Ltd, Mitsubishi Tanabe Pharma Co. and Konica Minolta Inc.; and has received honoraria from Sumitomo Dainippon Pharma Co Ltd, and FP Pharmaceutical Co. Koji Kawakami received collaborative research funds from Sumitomo Dainippon Pharma Co. Ltd., Novartis Pharma K.K., Bayer Yakuhin Ltd, Olympus Co., Stella Pharma Co., Cmic Holdings Co. Ltd., Pfizer Japan Inc., and Astellas Amgen BioPharma K.K.; consulting fees from Kaken Pharmaceutical Co. Ltd, and Kyowa Hakko Kirin Co. Ltd; honoraria from Otsuka Pharmaceutical, Santen Pharmaceutical, Takeda Pharmaceutical Co. Ltd., Novartis Pharm K.K., Bayer Yakuhin Ltd, Abbvie GK, Eisai Co Ltd, and Daiichi-Sankyo Co. Ltd. There are no patents, products in development, or marketed products to declare, relevant to the listed companies.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of study, the requirement for informed consent was waived by the institutional research committee.